Delivery Order SPE2DB20D3103-SPE2DB25FN3V2

Award Date 4/9/25
Potential Completion Date 4/10/25
Potential Value $38K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,405.44, is a Firm Fixed Price delivery order for the supply of 4567887605 - FERUMOXYTOL 510 MG/17 ML VIAL 17ML. The contract has an ultimate completion date of April 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $2,511.22, for the supply of FERUMOXYTOL 510 MG/17 ML VIAL 17ML. The contract has an ultimate completion date of March 11, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award, with a ceiling value of $10,532.05, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,917.30 firm fixed-price delivery order is for the supply of FERUMOXYTOL 510 MG/17 ML VIAL 17ML, a pharmaceutical product. The contract has a 2-year period of performance ending on December 24, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide...
This federal contract award, valued at $2,425.64, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FERUMOXYTOL 510 MG/17 ML VIAL 17ML, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of December 30, 2024 and is a Firm Fixed Price Delivery Order. It is not designated as a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FERUMOXYTOL 510 MG/17 ML VIAL 17ML, a medical product used in healthcare settings. The contract has a firm fixed-price pricing type and a ceiling value of $1,117.20. The contract term extends to February 14, 2025. The place of performance is Conshohocken, PA. This contract is...
This is a $1,867.52 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of FERUMOXYTOL 510 MG/17 ML VIAL 17ML, a medical product. The contract is not designated as a set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,214.82, is a delivery order for the supply of Ferumoxytol 510 mg/17 ml vial, a medical product used for various therapeutic applications. The contract has a firm fixed-price pricing type and a completion date of November 4, 2024. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp (Vendor ID: TGxsdkVQRGhOYUpNR001SFhYREdNdz09) was issued by the Defense Logistics Agency (DLA), a defense agency, on December 5, 2024. The $2,793.00 firm fixed-price delivery order is for the supply of 4566623601 - FERUMOXYTOL 510 MG/17 ML VIAL 17ML, with a final completion date of December 6, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,966.41 delivery order is for the supply of 510 mg/17 mL vials of the drug ferumoxytol. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FN3V2
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FERUMOXYTOL 510 MG/17 ML VIAL 17ML, a pharmaceutical product, with a ceiling value of $38,313.93 and a completion date of April 10, 2025.

The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract award does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and there is no mention of major subcontractors in the provided information.

Generated 7/9/25, 9:44 AM